GET STARTED FOR FREE
REGISTER FOR FREE to get instant access to search Sites, Inspections & Warning Letters
TAGGED & SEARCHABLE DATA
FOCUS ON THE DATA THAT MATTERS
All in-stock 483s have been retyped and tagged with keywords to help you quickly analyze the data you are interested in.
Filter searches by industry keywords and site tags.
Segment by FDA Industry, region, document type, and more.
KNOW WHERE TO CONCENTRATE YOUR EFFORTS
Identify the most common issues and focus areas.
Link to all inspections and citation data.
Reveal most-common co-inspectors.
TRENDS & BENCHMARKS
ELIMINATE UNWANTED SURPRISES
Benchmark performance relative to your peer group, which creates the business case for preemptive corrective actions.
Be one step ahead of the FDA by determining key areas of focus.
Align your budget and CAPAs to the top issues and emerging trends.
Yet another week with a preponderance of warning letters issued by the Center for Tobacco Products. We cover one warning letter issued to an OTC manufacturer in China.
How Key Pharma and Device Executives Are Developing the Next Generation of Quality Professionals and Leaders
A team comprising over a dozen chief quality officers (CQOs) representing the medical device, pharmaceutical, animal health, and consumer healthcare industries has pooled its collective passion and wisdom – with input from FDA and other drug and device regulatory agencies – to establish and implement an innovative education curriculum that will help develop the next generation of scientists entering the industry.